LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 2.91X leverage
Performance
- Low
- ₹601
- High
- ₹677
- 52 Week Low
- ₹440
- 52 Week High
- ₹696
- Open Price₹605
- Previous Close₹616
- Volume738,475
- 50 DMA₹495.89
- 100 DMA₹506.35
- 200 DMA₹533.57
Investment Returns
- Over 1 Month + 36.67%
- Over 3 Month + 29.31%
- Over 6 Month + 20.18%
- Over 1 Year + 2.01%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.9
- PEG Ratio
- -8.7
- Market Cap Cr
- 1,311
- P/B Ratio
- 1.8
- Average True Range
- 31.71
- EPS
- 43.85
- Dividend Yield
- 0.3
- MACD Signal
- 6.88
- RSI
- 83.55
- MFI
- 97.94
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹654.30
+
38.5
(6.25%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹508.34
- 50 Day
- ₹495.89
- 100 Day
- ₹506.35
- 200 Day
- ₹533.57
Resistance and Support
644.2
- R3 762.80
- R2 719.90
- R1 687.10
- S1 611.40
- S2 568.50
- S3 535.70
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹654 As on 15 February, 2026 | 01:53
The Market Cap of Lincoln Pharmaceuticals is ₹1310.5 Cr As on 15 February, 2026 | 01:53
The P/E ratio of Lincoln Pharmaceuticals is 14.9 As on 15 February, 2026 | 01:53
The PB ratio of Lincoln Pharmaceuticals is 1.8 As on 15 February, 2026 | 01:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.